Syncona Partners LLP Investor

Syncona Partners LLP was founded in 2012 and operates as an evergreen investment company, taking an active role in identifying, supporting and developing technologies with the potential to significantly impact the healthcare market of the future. Syncona is an investor that can take the long view when necessary, able to concentrate investment into opportunities as technology is validated.
Syncona Partners is an independent subsidiary of the Wellcome Trust who invested the initial £200m capitalisation. Syncona Partners provides financial resources to individuals and companies to advance the Wellcome Trust’s vision of achieving extraordinary improvements in human and animal health by supporting the brightest minds in biomedical research and the medical humanities.
Industry: Regenerative Medicine
Headquarters: London, England, United Kingdom
Founded Date: 2012
Employees Number: 11-50
Funding Status: IPO
Investor Type: Venture Capital
Investment Stage: N/A
Number Of Exits: 2

Visit Website
contact@synconaltd.com
Register and Claim Ownership